{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:34:00Z","timestamp":1774434840046,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12325-023-02459-4","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T14:02:37Z","timestamp":1677333757000},"page":"1884-1898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and Effectiveness Analyses of Dolutegravir\/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-0843","authenticated-orcid":false,"given":"Ayano","family":"Tofukuji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5076-3717","authenticated-orcid":false,"given":"Haruyuki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1154-7090","authenticated-orcid":false,"given":"Takako","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akemi","family":"Sebata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Maeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-2084","authenticated-orcid":false,"given":"Akiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"2459_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS data 2021. 2021. https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021_unaids_data. Accessed 1 Dec 2022."},{"key":"2459_CR2","unstructured":"AIDS Prevention Information Network. Table 2: Cumulative number of reports of HIV-infected and AIDS-infected patients by nationality, sex, and route of transmission. Published on Mar 15, 2022. https:\/\/api-net.jfap.or.jp\/status\/japan\/index.html. Accessed 1 Dec 2022."},{"key":"2459_CR3","unstructured":"Health and Labour Sciences Research Grants, Research on HIV\/AIDS, Ministry of Health, Labour and Welfare, Japan. Anti-HIV treatment guidelines. 2022. https:\/\/hiv-guidelines.jp\/index.htm. Accessed 1 Dec 2022."},{"issue":"6","key":"2459_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/ciac036","volume":"75","author":"O Osiyemi","year":"2022","unstructured":"Osiyemi O, De Wit S, Ajana F, et al. Efficacy and safety of switching to dolutegravir\/lamivudine versus continuing a tenofovir alafenamide-based 3- or 4-drug regimen for maintenance of virologic suppression in adults living with human immunodeficiency virus type 1: results through week 144 from the phase 3, noninferiority TANGO randomized trial. Clin Infect Dis. 2022;75(6):975\u201386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2459_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAD.0000000000003070","volume":"36","author":"P Cahn","year":"2022","unstructured":"Cahn P, Sierra Madero J, Arribas JR, et al. Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy\u2014naive adults with HIV-1 infection. AIDS. 2022;36(1):39\u201348.","journal-title":"AIDS"},{"issue":"16","key":"2459_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jama.2020.17025","volume":"324","author":"MS Saag","year":"2020","unstructured":"Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society\u2013USA Panel. JAMA. 2020;324(16):1651\u201369.","journal-title":"JAMA"},{"key":"2459_CR7","unstructured":"US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2022. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-arv\/guidelines-adult-adolescent-arv.pdf. Accessed 1 Dec 2022."},{"key":"2459_CR8","unstructured":"European AIDS Clinical Society. EACS Guidelines Version 11.1. 2022. https:\/\/www.eacsociety.org\/media\/guidelines-11.1_final_09-10.pdf. Accessed 1 Dec 2022."},{"key":"2459_CR9","unstructured":"Dovato Combination Tablets Package Insert (in Japanese). Pharmaceuticals and Medical Devices Agency, Japan. 2021. https:\/\/www.pmda.go.jp\/. Accessed 1 Dec 2022."},{"issue":"12","key":"2459_CR10","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/QAD.0000000000002979","volume":"35","author":"CP Rolle","year":"2021","unstructured":"Rolle CP, Berhe M, Singh T, et al. Dolutegravir\/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV. AIDS. 2021;35(12):1957\u201365.","journal-title":"AIDS"},{"key":"2459_CR11","unstructured":"AIDS 2022 Organizing Committee. AIDS 2022 abstract book. 2022. https:\/\/aids2022.org\/wp-content\/uploads\/2022\/08\/AIDS2022_abstract_book.pdf. Accessed 1 Dec 2022."},{"issue":"11","key":"2459_CR12","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1001\/jama.290.11.1510","volume":"290","author":"MR Golden","year":"2003","unstructured":"Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003;290(11):1510\u20134.","journal-title":"JAMA"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02459-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02459-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02459-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T10:41:16Z","timestamp":1680518476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02459-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02459-4","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}